Overexpression of S100A2/A3/A4/A5/A6/A10/A11/A13/A14/A16/P in pancreatic cancer is positively correlated with TP53 mutation, while the high expression of S100A1/B/Z is negatively correlated with TP53 mutation. Here, S100A2 is linked to pancreatic neoplasm.